WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.


Temperatures to Drop Over the Weekend
Documents on Nixa Woman Accused of Impersonating Celebrities Posted
Christmas Events This Weekend in the Lakes Region
Drought Levels Steady in Lakes Region